America's broken drug system: Short supplies, randomly rising prices and no solution in sight
Martin Shkreli this month became the face of what’s wrong with the U.S. drug industry.
A congressional committee hauled in the former chief of Turing Pharmaceuticals and asked him to justify boosting the price of a lifesaving drug by 5,000 percent, charging $750 per pill for a drug that had sold for $13.50.